Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pyoderma.

C H Dicken

    Journal of the American Academy of Dermatology
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Malignant pyoderma, a rare skin disease, typically affects young adults. This study reports a case successfully treated with isotretinoin and sulfapyridine, achieving complete remission.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C.

    Mayo Clinic proceedings·1998
    Same author

    Recognizing cutaneous drug eruptions. Reaction patterns provide clues to causes.

    Postgraduate medicine·1998
    Same author

    Trigeminal trophic syndrome.

    Mayo Clinic proceedings·1997
    Same author

    Anetoderma after hepatitis B immunization in two siblings.

    Journal of the American Academy of Dermatology·1997
    Same author

    Indeterminate cell histiocytosis treated successfully with 2-chlorodeoxyadenosine.

    Cutis·1997
    Same author

    Pancreatic panniculitis.

    Journal of the American Academy of Dermatology·1995
    Same journal

    Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

    Journal of the American Academy of Dermatology·2026
    Same journal

    First-Come, First-Served: Ethics of Coordinated Interview Releases.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Rare Diseases
    • Clinical Case Reports

    Background:

    • Malignant pyoderma is a rare, destructive, ulcerating skin condition primarily affecting young adults.
    • It characteristically involves the head and neck, often with a predilection for the periauricular area.

    Observation:

    • The disease is progressive and chronic, with reported cases limited to eight prior to this study.
    • Systemic corticosteroids can induce responses but are often associated with disease flares upon dose reduction.

    Findings:

    • This report details an additional case of malignant pyoderma.
    • Complete remission was achieved using a combination therapy of isotretinoin and sulfapyridine.

    Implications:

    • This suggests a potential novel therapeutic approach for malignant pyoderma.
    • Further research into combination therapies may offer improved outcomes for this rare dermatosis.